A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Phase 2
Terminated
- Conditions
- Anterior Uveitis
- Registration Number
- NCT00333996
- Lead Sponsor
- Allergan
- Brief Summary
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
- 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye
Exclusion Criteria
- Uncontrolled systemic disease
- Any active ocular infections
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Anterior Chamber Cell
- Secondary Outcome Measures
Name Time Method